(Post-pandemic Era)-Global Point of Care (PoC) Molecular Diagnostics Market Assessment, With Major Companies Analysis, Regional Analysis, Breakdown Data by Application/Type

Table of Contents

Global Point of Care (PoC) Molecular Diagnostics Market Analysis 2020, With Top Companies, Production, Revenue, Consumption, Price and Growth Rate
1 Market Scope
    1.1 Product Details and Introduction
      1.1.1 Polymerase Chain Reaction (Real Time PCR) -Product Introduction and Major Manufacturers
      1.1.2 In Situ Hybridization -Product Introduction and Major Manufacturers
      1.1.3 Chips and Microarrays -Product Introduction and Major Manufacturers
      1.1.4 Mass Spectrometry -Product Introduction and Major Manufacturers
      1.1.5 Sequencing -Product Introduction and Major Manufacturers
      1.1.6 Isothermal Amplification -Product Introduction and Major Manufacturers
      1.1.7 Others -Product Introduction and Major Manufacturers
    1.2 Market Snapshot
      1.2.1 Major Companies Overview
      1.2.2 Market Concentration
      1.2.3 Six-Year Compound Annual Growth Rate (CAGR)
2 Regional Market
    2.1 Regional Market Share in Terms of Production (2019-2026)
    2.2 Regional Market Share in Terms of Revenue (2019-2026)
    2.3 Regional Market Share in Terms of Consumption (2019-2026)
3 Global Point of Care (PoC) Molecular Diagnostics Market Assessment by Type
    3.1 Global Point of Care (PoC) Molecular Diagnostics Production by Type (2015-2026)
    3.2 Global Point of Care (PoC) Molecular Diagnostics Revenue by Type (2015-2026)
    3.3 North America Point of Care (PoC) Molecular Diagnostics Production and Revenue by Type (2015-2026)
    3.4 Asia Point of Care (PoC) Molecular Diagnostics Production and Revenue by Type (2015-2026)
    3.5 Europe Point of Care (PoC) Molecular Diagnostics Production and Revenue by Type (2015-2026)
    3.6 Middle East & Africa Point of Care (PoC) Molecular Diagnostics Production and Revenue by Type (2015-2026)
    3.7 South America Point of Care (PoC) Molecular Diagnostics Production and Revenue by Type (2015-2026)

4 Global Point of Care (PoC) Molecular Diagnostics Market Assessment by Application
    4.1 Historical & Forecast Global Point of Care (PoC) Molecular Diagnostics Consumption, Different Application Field (2015-2026)
    4.2 Historical & Forecast North America Point of Care (PoC) Molecular Diagnostics Consumption, Different Application Field (2015-2026)
    4.3 Historical & Forecast Asia Point of Care (PoC) Molecular Diagnostics Consumption, Different Application Field (2015-2026)
    4.4 Historical & Forecast Europe Point of Care (PoC) Molecular Diagnostics Consumption, Different Application Field (2015-2026)
    4.5 Historical & Forecast Middle East & Africa Point of Care (PoC) Molecular Diagnostics Consumption, Different Application Field (2015-2026)
    4.6 Historical & Forecast South America Point of Care (PoC) Molecular Diagnostics Consumption, Different Application Field (2015-2026)

5 North America
    5.1 US Point of Care (PoC) Molecular Diagnostics Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)
    5.2 Canada Point of Care (PoC) Molecular Diagnostics Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)
    5.3 Mexico Point of Care (PoC) Molecular Diagnostics Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)
6 Asia
    6.1 China Point of Care (PoC) Molecular Diagnostics Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)
    6.2 Japan Point of Care (PoC) Molecular Diagnostics Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)
    6.3 India Point of Care (PoC) Molecular Diagnostics Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)
    6.4 Korea Point of Care (PoC) Molecular Diagnostics Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)
    6.5 Southeat Asia Point of Care (PoC) Molecular Diagnostics Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)
7 Europe
    7.1 Germany Point of Care (PoC) Molecular Diagnostics Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)
    7.2 UK Point of Care (PoC) Molecular Diagnostics Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)
    7.3 France Point of Care (PoC) Molecular Diagnostics Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)
    7.4 Russia Point of Care (PoC) Molecular Diagnostics Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)
    7.5 Italy Point of Care (PoC) Molecular Diagnostics Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)
8 Middle East and Africa
    8.1 Saudi Point of Care (PoC) Molecular Diagnostics Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)
    8.2 UAE Point of Care (PoC) Molecular Diagnostics Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)
    8.3 Egypt Point of Care (PoC) Molecular Diagnostics Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)
    8.4 Nigeria Point of Care (PoC) Molecular Diagnostics Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)
    8.5 South Africa Point of Care (PoC) Molecular Diagnostics Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)
9 South America
    9.1 Brazil Point of Care (PoC) Molecular Diagnostics Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)
    9.2 Argentina Point of Care (PoC) Molecular Diagnostics Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)
    9.3 Colombia Point of Care (PoC) Molecular Diagnostics Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)
10 Global Point of Care (PoC) Molecular Diagnostics Average Price Trend
    10.1 Market Price for Each Type of Point of Care (PoC) Molecular Diagnostics in North America (2015-2026)
    10.2 Market Price for Each Type of Point of Care (PoC) Molecular Diagnostics in Asia (2015-2026)
    10.3 Market Price for Each Type of Point of Care (PoC) Molecular Diagnostics in Europe (2015-2026)
    10.4 Market Price for Each Type of Point of Care (PoC) Molecular Diagnostics in Middle East & Africa (2015-2026)
    10.5 Market Price for Each Type of Point of Care (PoC) Molecular Diagnostics in South America (2015-2026)

11 Value Chain (Impact of COVID-19)
    11.1 Point of Care (PoC) Molecular Diagnostics Value Chain Analysis
      11.1.1 Upstream
      11.1.2 Downstream
    11.2 COVID-19 Impact on Point of Care (PoC) Molecular Diagnostics Industry
      11.2.1 Industrial Policy Issued Under the Epidemic Situation
    11.3 Cost-Under the Epidemic Situation
      11.3.1 Cost of Raw Material
    11.4 Channel Analysis
      11.4.1 Distribution Channel-Under the Epidemic Situation
      11.4.2 Distributors

12 Point of Care (PoC) Molecular Diagnostics Competitive Analysis
     12.1 Bayer Corporation
        12.1.1 Bayer Corporation Company Profiles
        12.1.2 Bayer Corporation Product Introduction
        12.1.3 Bayer Corporation Point of Care (PoC) Molecular Diagnostics Production, Revenue (2015-2020)
        12.1.4 SWOT Analysis
     12.2 Roche Diagnostics
        12.2.1 Roche Diagnostics Company Profiles
        12.2.2 Roche Diagnostics Product Introduction
        12.2.3 Roche Diagnostics Point of Care (PoC) Molecular Diagnostics Production, Revenue (2015-2020)
        12.2.4 SWOT Analysis
     12.3 Sysmex Corporation
        12.3.1 Sysmex Corporation Company Profiles
        12.3.2 Sysmex Corporation Product Introduction
        12.3.3 Sysmex Corporation Point of Care (PoC) Molecular Diagnostics Production, Revenue (2015-2020)
        12.3.4 SWOT Analysis
     12.4 Abaxis
        12.4.1 Abaxis Company Profiles
        12.4.2 Abaxis Product Introduction
        12.4.3 Abaxis Point of Care (PoC) Molecular Diagnostics Production, Revenue (2015-2020)
        12.4.4 SWOT Analysis
     12.5 OraSure Technologies
        12.5.1 Abbott Laboratories Company Profiles
        12.5.2 Abbott Laboratories Product Introduction
        12.5.3 Abbott Laboratories Point of Care (PoC) Molecular Diagnostics Production, Revenue (2015-2020)
        12.5.4 SWOT Analysis
     12.6 BioMerieux SA
        12.6.1 BioMerieux SA Company Profiles
        12.6.2 BioMerieux SA Product Introduction
        12.6.3 BioMerieux SA Point of Care (PoC) Molecular Diagnostics Production, Revenue (2015-2020)
        12.6.4 SWOT Analysis
     12.7 Bio-Rad Laboratories
        12.7.1 Bio-Rad Laboratories Company Profiles
        12.7.2 Bio-Rad Laboratories Product Introduction
        12.7.3 Bio-Rad Laboratories Point of Care (PoC) Molecular Diagnostics Production, Revenue (2015-2020)
        12.7.4 SWOT Analysis
     12.8 Danaher Corporation
        12.8.1 Danaher Corporation Company Profiles
        12.8.2 Danaher Corporation Product Introduction
        12.8.3 Danaher Corporation Point of Care (PoC) Molecular Diagnostics Production, Revenue (2015-2020)
        12.8.4 SWOT Analysis
     12.9 OraSure Technologies
        12.9.1 OraSure Technologies Company Profiles
        12.9.2 OraSure Technologies Product Introduction
        12.9.3 OraSure Technologies Point of Care (PoC) Molecular Diagnostics Production, Revenue (2015-2020)
        12.9.4 SWOT Analysis
13 Conclusion